Pfizer
Crizotinib-xalkori
"Crizotinib" is the Drug / Molecule content in "Xalkori”. It has an aminopyridine structure, and functions as a protein kinase inhibitor Crizotinib blocks an enzyme called anaplastic lymphoma kinase (ALK). Blocking this enzyme stops the growth of cells.
Indication
Crizotinib is used for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in a gene called ALK (anaplastic lymphoma kinase).
Note
Precaution
- Crizotinib is a prescription drug and should be used under proper medical guidance and advice.
- Do not receive any kind of immunization or vaccination without your doctor's approval while taking Crizotinib.
Strength
200 mg & 250 mg
Packing
1 X 60 Tablets (Bottle)
Storage
Store at room Temperature (25 C).
Was this page helpful?
Related Products
CIPLA LTD. (INDIA)
Pirfenex
NATCO PHARMA LIMITED (INDIA)
Erlonat
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Gefitinib-geftinat
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)